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Abstract: Psychoactive drugs are frequently detected in the aquatic environment. The evolutionary conservation of themolecular targets
of these drugs in ﬁsh suggests that theymay elicit mode of action–mediated effects in ﬁsh as they do in humans, and the key open question
is at what exposure concentrations these effects might occur. In the present study, the authors investigated the uptake and tissue
distribution of the benzodiazepine oxazepam in the fathead minnow (Pimephales promelas) after 28 d of waterborne exposure to
0.8mg L1, 4.7mg L1, and 30.6mg L1. Successively, they explored the relationship between the internal concentrations of oxazepam
and the effects on ﬁsh exploratory behavior quantiﬁed by performing 2 types of behavioral tests, the novel tank diving test and the shelter-
seeking test. The highest internal concentrations of oxazepam were found in brain, followed by plasma and liver, whereas muscle
presented the lowest values. Average concentrations measured in the plasma of ﬁsh from the 3 exposure groups were, respectively,
8.7 5.7mg L1, 30.3 16.1mg L1, and 98.8 72.9mg L1. Signiﬁcant correlations between plasma and tissue concentrations of
oxazepam were found in all 3 groups. Exposure of ﬁsh to 30.6mg L1 in water produced plasma concentrations within or just below the
human therapeutic plasma concentration (HTPC) range in many individuals. Statistically signiﬁcant behavioral effects in the novel tank
diving test were observed in ﬁsh exposed to 4.7mg L1. In this group, plasma concentrations of oxazepam were approximately one-third
of the lowest HTPC value. No signiﬁcant effects were observed in ﬁsh exposed to the lowest and highest concentrations. The signiﬁcance
of these results is discussed in the context of the species-speciﬁc behavior of fathead minnow and existing knowledge of oxazepam
pharmacology. Environ Toxicol Chem 2016;35:2782–2790.# 2016 The Authors. Environmental Toxicology and Chemistry published
by Wiley Periodicals, Inc. on behalf of SETAC.
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INTRODUCTION
In recent years, interest in the potential effects of
psychoactive pharmaceuticals in aquatic organisms has grown
rapidly, mainly because of the frequent detection of these
compounds in the aquatic environment [1]. Several psychoac-
tive drugs have been detected in surface waters, generally in the
nanograms per liter range [1,2], as well as in ﬁsh tissues [3,4],
ﬁsh plasma [5], invertebrates [6], and bioﬁlm [7], usually in the
low nanograms per gram range. An increasing number of
studies have reported a range of biochemical and behavioral
effects of these compounds in aquatic organisms across an
extremely wide range of exposure concentrations (picograms
per liter to milligrams per liter). Because of the apparent highly
variable potency of these compounds in aquatic organisms, the
environmental implications of exposure to these drugs are as yet
unclear [1].
Among these psychoactive compounds, the benzodiazepine
oxazepam has received signiﬁcant attention after a recent report
in which relatively low concentrations (1.8mg L1) affected the
behavior of wild ﬁsh inhabiting Swedish surface waters [8].
Oxazepam is a drug widely used for the treatment of anxiety
but is also prescribed to treat insomnia and acute alcohol
withdrawal. Oxazepam acts as an agonist of an allosteric binding
site on theg-aminobutyric acid subtypeA (GABAA) receptor and
increases the binding efﬁciency of GABA binding, a major
inhibitory neurotransmitter and key regulator of anxiety [9],
leading to a reductionof the communication betweenneurons and
hence to a calming effect in the brain [10,11]. Importantly, this
neurotransmitter system is well conserved in teleost ﬁsh: several
studies have identiﬁed benzodiazepine–GABA receptors in ﬁsh
and shown that they have similar binding characteristics as those
present in mammals [12,13]. Moreover, exposure of zebraﬁsh to
GABA–enhancing drugs, such as diazepam (another benzodiaz-
epine drug), has been shown to have an anxiolytic effect, thus
conﬁrming that ﬁsh are sensitive to GABA modulation and
respond to benzodiazepines [14]. The conservation of the drug
target in ﬁsh supports the hypothesis that exposure to oxazepam
may lead to a mode of action–mediated effect in ﬁsh, as it does in
humans [11,15].
Considering the importance of characterizing accurate effect
concentrations to better inform the environmental risk assess-
ment of pharmaceuticals, the aim of the present study was to
investigate,ﬁrstly, the uptake and tissue distribution of oxazepam
in the fathead minnow (Pimephales promelas) after chronic
waterborne exposure and, secondly, the relationship between
internal concentrations of oxazepam and behavioral effects.
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The experimental design was driven by the “read-across”
approach [5,16], according to which the human therapeutic
plasma concentrations of a given drug can be used as reference
to predict the likelihood of occurrence of relevant mode of
action–mediated effects in ﬁsh at comparable levels of
biological organization. The closer the drug concentration in
ﬁsh plasma is to the human therapeutic plasma concentration
(HTPC), the higher is the probability to observe the effect (i.e.,
behavioral alterations) [16]. This approach can be used to
estimate the water concentration that will elicit a therapeutic
effect in ﬁsh and can therefore drive the selection of the
exposure concentrations and test speciﬁc hypotheses. This
approach has been successfully applied in previous studies on
antidepressant drugs by Margiotta-Casaluci et al. [5] and
Valenti et al. [17]. In the present study, the exposure
concentrations were selected to produce drug plasma concen-
trations in ﬁsh within the HTPC in 1 group of ﬁsh and lower than
the HTPC range in another 2 groups. This designwas intended to
test whether behavioral effects occur only at plasma concen-
trations equal to the HTPC, or also at lower concentrations.
MATERIALS AND METHODS
Chemicals
Oxazepam (CAS no. 604-75-1) was purchased from Sigma-
Aldrich with purity higher than 98%. Stock solutions were
prepared every 7 d in N,N-dimethylformamide (Fisher Scien-
tiﬁc) in amber bottles to preserve them from light exposure.
High-performance liquid chromatography (HPLC)–grade
methanol, acetonitrile, water, and formic acid (98%) were
supplied by Merck. The OstroTM 96-well plate used for
puriﬁcation of plasma samples was acquired from Waters.
Dechlorinated tap water (5mm and 10mm carbon-ﬁltered) was
used as dilution water, and general parameters (pH, tempera-
ture, and dissolved oxygen) were monitored daily throughout
the study.
Test species and ethical statement
Adult fathead minnows (P. promelas) were supplied from
breeding stocks maintained at Brunel University (London, UK).
Two weeks before the beginning of the present study sexually
mature males and females were separated to prevent any
spawning activity and acclimated to the test conditions. Fish
were fed 3 times/d: once with adult brine shrimp (Tropical
Marine Centre; Gamma-irradiated) and twice with ﬂake food
(King British Tropical ﬂake food). Fish were not fed on the
sampling day. The present study was carried out under Project
and Personnel Licences granted by the UK Home Ofﬁce, under
the United Kingdom Animals (Scientiﬁc Procedures) Act 1986,
and European Animal Directive 2010/63/EU.
Experimental design
The 28-d exposure was carried out using a continuous ﬂow-
through system comprising 16 20-L glass tanks (455mm
length 260mm width 250mm depth). The test was run at a
water temperature of 25 1 8C, with a 16:8-h light:dark
photoperiod, with 20-min dawn/dusk transition periods.
During the experiment, dissolved oxygen concentrations
were maintained between 6.4mgL1 and 7.8mgL1, and pH
was 7.5 (0.5).Water ﬂowed into the 16 glass mixing chambers
at a rate of 222mLmin1, which supplied 16 tank volumes/d to
each test tank. The same mixing chambers also received
concentrated stock solutions of oxazepam delivered via
peristaltic pumps at a rate of 0.1mLmin1. In total, there
were 4 exposure tanks/treatment (2 for males and 2 for females)
for each of 4 treatments (0mg L1, 1mgL1, 5mg L1, and
25mg L1). Eight males or females were randomly allocated to
the appropriate tanks, giving a total of 32 ﬁsh/treatment (16
males and 16 females). Both the allocation of the treatment
groups in the experimental room and the allocation of each ﬁsh
into 1 of the 16 tanks were randomized with the aid of a random
number generator.
Exposure concentrations were selected to cover both
pharmacologically and environmentally relevant concentra-
tions. The selection of external exposure (water) concentrations
expected to result in pharmacologically relevant internal
(plasma) concentrations was driven by application of the ﬁsh
plasma model of Huggett et al. [18] and information on the
HTPC of oxazepam. The latter was obtained from a study in
which patients were administered 15mg and 30mg of
oxazepam on 2 separate occasions with a 7-d interval, which
produced therapeutic plasma concentrations in the range
100 ngmL1 to 280 ngmL1 [19].
After the 26-d exposure, 2 behavioral tests, the shelter-
seeking test and the novel tank diving test, were performed on
all ﬁsh as detailed in the next section, Analysis of oxazepam in
water, ﬁsh plasma, and other tissues. On the day 28 of exposure,
ﬁsh were terminally anesthetized according to UK Home Ofﬁce
regulations using a buffered ethyl 3-aminobenzoate methane
sulfonate solution (MS-222; 0.5 g L1, pH 7.5; Sigma; CAS no.
144-55-8). Standard length and wet weight were measured, and
blood was taken from the caudal vein using heparinized
capillary tubes. Blood samples were centrifuged at 4 8C at
10 000 g for 6min; plasma was collected and stored at –80 8C
until analysis; and brain, muscle, and liver were removed,
weighed, snap-frozen in liquid nitrogen, and stored at –80 8C
until subsequent analysis.
Analysis of oxazepam in water, fish plasma, and other tissues
Water samples (40mL) for the chemical analysis were
collected in Falcon tubes on days 0, 7, 14, 21, and 28 from all
tanks and kept at –20 8C until analysis. For analysis, 1mL of
each sample was centrifuged at 8000 rpm for 10min, after
which 10mL of each sample was directly injected in the detector
without further extraction. For plasma samples, acetonitrile
(400mL)was added to 50mL of plasma and vortexed for 30 s for
protein precipitation. Samples were then transferred to an Ostro
96-well plate connected to a vacuum system for the removal of
phospholipids. An aliquot of 300mL was collected from each
extract and placed under an N2 current to dry completely.
Finally, extracts were dissolved in 100mL of a 1:1 mixture of
methanol to water. Five microliters of diazepam-d5, prepared at
1mgmL1 in methanol, was added as an internal standard to
each extract to account for matrix effects during subsequent
analysis.
Brain, liver, and muscle samples were extracted using a
method adapted from that of Valdes et al. [20]. Samples
(ranging 20–200mg) were sonicated in 1mL of methanol for
15min and then centrifuged at 10 000 rpm for 10min. After this
procedure was repeated 3 times, the supernatant was collected,
pooled, and evaporated to dryness. Extracts were subsequently
dissolved in 1mL of HPLC-grade water and then puriﬁed in a
solid-phase extraction Oasis HLB 96-well plate. Solid-phase
extraction sorbent in the wells was previously conditioned with
1mL of methanol and 1mL of HPLC-grade water at a ﬂow of
0.5mLmin1, with extracts being loaded at the same ﬂow rate.
After drying the well for 5min, 1mL of methanol was loaded in
the plate to elute the samples, which were collected and placed
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under an N2 current to dry completely. Finally, extracts were
dissolved in 750mL of amixture of methanol andwater (1:1) for
analysis. Ten microliters of diazepam-d5, prepared at 1mg
mL1 in methanol, was added to each extract to account for
matrix effects during analysis.
All extracts were analyzed by ultra-HPLC (Waters) coupled
to a hybrid quadrupole linear ion trap mass spectrometer (Qtrap
5500; Applied Biosystems), equipped with an electrospray
ionization source in positive mode. Ten microliters was injected
in an Acquity HSS T3 column, with 10mM formic acid/
ammonium formate (pH 3.2) and methanol as the mobile phase
set at a ﬂow rate of 0.5mLmin1.
Compound-dependent mass spectrometric parameters (de-
clustering potential, collision energy, and collision cell exit
potential) as well as compound-selected reaction monitoring
transitions were optimized by direct infusion of individual
standard solution of each analyte at 10 ngmL1. A summary of
these parameters is presented in Supplemental Data, Table S1.
All transitions were recorded in a scheduled multiple reaction
monitoring algorithm with a 30-s detection window. Source-
dependent parameters were determined by ﬂow injection
analysis: curtain gas, 30V; nitrogen collision gas, medium;
source temperature, 500 8C; ion spray voltage, 5500; ion spray
gases 1¼ 60V and 2¼ 50V. Instrument control data acquisi-
tion and data analysis were carried out using Analyst software
(Applied Biosystems).
Prediction of oxazepam plasma concentration using the fish
plasma model
Measured plasma concentrations were compared with the
concentrations predicted by the ﬁsh plasma model [18]. The
model aims to predict the ﬁsh steady-state plasma concentration
of a drug starting from a certain water concentration and is based
on the following equations:
logPBlood:Water ¼ 0:73 logD7:4  0:88
FssPC ¼ ½water concentration;mg=L  PBlood:Water
In these equations PBlood:Water represents the partitioning
between blood and the aqueous phase, log D7.4 is the logarithm
of the distribution coefﬁcient (D) at pH 7.4 for the drug of
interest, and FssPC is the ﬁsh steady-state plasma concentration.
Average water concentrations throughout the 28 d were used to
compare measured versus predicted plasma concentrations.
Analysis of fish behavior
Fish exploratory behavior was used as proxy to assess
potential oxazepam-induced behavioral effects [21]. On day 26,
2 behavioral tests, the novel tank diving test and the shelter-
seeking test, were performed on all ﬁsh (n¼ 128) as described
by Margiotta-Casaluci et al. [5] and Valenti et al. [17]. The
novel tank diving test is based on the instinctive behavior of
fathead minnow to seek protection in a novel environment by
diving to the bottom of the tank until the environmental
conditions are perceived as safe enough to initiate exploration.
Immediately before the initiation of the tests, each individual
ﬁsh was transferred from the exposure tank to a 9-L observation
tank (290mm length 345mmwidth 140mmdepth), and the
exploratory behavior of each ﬁsh individually was recorded for
15min, after 30-s acclimation, using a Fujiﬁlm digital camera
(FinePix JV300, 14.0 Mpix) positioned in front of the tank.
VideoTrack analysis software (ViewPoint) was used for the
ofﬂine analysis of ﬁsh exploratory behavior. The observation
tank was visually divided in 3 areas of equal size (bottom,
middle, top), and the following endpoints were quantiﬁed:
number of entries into the top and middle areas; percentage of
time spent at the bottom, middle, and top areas; and total
distance traveled. All ﬁshwere tested and returned to their tanks.
After 24 h, ﬁsh were transferred to a 12-L observation tank
(measuring 390mm length 200mm width 200mm depth)
for the shelter-seeking test. The shelter-seeking test is aimed at
quantifying the shelter-seeking behavior of ﬁshwhen placed in a
novel environment (i.e., the observation tank). In this test,
individual ﬁsh were transferred to a 12-L observation tank
(measuring 390mm length 200mm width 200mm depth).
Each tank contained a tile (i.e., representing the shelter for the
ﬁsh) placed equidistantly from the tank walls. The exploratory
behavior of each ﬁsh was recorded for 15min, after 30-s
acclimation, using a Fujiﬁlm digital camera positioned on the
top of the tank. Also in this case, VideoTrack analysis software
was used for the ofﬂine analysis of ﬁsh exploratory behavior,
which included quantiﬁcation of the time spent under or outside
the shelter and the total distance traveled. Four observational
tanks were ﬁlmed at the same time in both tests.
Data analysis
Bioaccumulation data were analyzed by the multiple
comparison Holm-Sidak test, with analysis of variance
assumptions of normality and identical standard deviation
(SD) conﬁrmed by D’Agostino-Pearson normality test and
Bartlett’s test, respectively. All behavioral endpoints were
analyzed for treatment-related differences in the medians by the
nonparametric Dunn’s multiple comparison test. Statistical
signiﬁcance was set at p< 0.05 in all cases. A more in-depth
analysis by marginal logistic regression was performed. The
inﬂuence of plasma levels (categorized by their tertiles) and
gender on selected behavioral endpoints was examined, the
information was reduced to dichotomous levels, and the
probability of the behavioral occurrence was estimated in
relation to the controls. The analysis accounted for a potential
tank correlation effect. Results are reported as odds ratios with
95% conﬁdence intervals, corrected for multiple comparisons
(Dunnett). All statistical analyses were conducted using the
software SAS (SAS Institute).
RESULTS AND DISCUSSION
Oxazepam concentrations in water, plasma, brain, and muscle
Recoveries, method detection and quantiﬁcation limits,
precision, and accuracy for the analysis of oxazepam in water,
ﬁsh plasma brain, liver, and muscle are summarized in Table 1
(see also Supplemental Data). Average water concentrations
measured throughout the experiment for the lowest, medium,
and highest treatment concentrations were 0.8 0.2mg L1,
4.7 0.5mg L1, and 30.6 2.9mg L1 (mean SD, n¼ 20),
respectively. During the 5 sampling events, measured concen-
trations were within 20% of the nominal concentration in all
tanks.
Measured concentrations of oxazepam in plasma of fathead
minnows are shown in Table 2 and Supplemental Data,
Table S2. All samples in the control group had concentrations
below the method detection limits, whereas an increasingly high
concentration of oxazepam in plasma was observed at higher
exposure concentrations. Average concentrations of oxazepam
measured in plasma were 8.7 5.7mg L1, 30.3 16.1mg L1,
and 98.8 72.9mgL1 (mean SD, n¼ 32) for the 0.8mg L1,
4.7mg L1, and 30.6mgL1 treatment groups, respectively.
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Observed interindividual variability in oxazepam plasma
concentrations for ﬁsh from the same tank was within the range
of 3-fold to 6-fold for 9 out of 12 tanks (Supplemental Data,
Table S3). In the 3 remaining tanks, the higher variation was
caused by a few samples in which very low concentrations of
oxazepam were quantiﬁed. If the 5th and 95th percentile values
are used, the ratio maximum to minimum in those 3 tanks
reduces to the expected range (2.5-fold to 4.2-fold). This degree
of intratank variability was similar to that observed for another
psychoactive drug, ﬂuoxetine, by Margiotta-Casaluci et al. [5].
Determining the distribution of the drug in the body and
potential bioaccumulation dynamics is critical to inform the
future development of uptake and pharmacokinetics models
able to predict those processes in conditions of chronic
exposure [5]. The development of those models is in fact often
constrained by the availability of empirical data. Characteriza-
tion of distribution is particularly important for drugs like
oxazepam which act on a speciﬁc system (i.e., central nervous
system).
The concentrations of oxazepam in the liver, brain, and
muscle of exposed ﬁsh are summarized in Table 2 and
Supplemental Data, Table S2. The highest concentrations
were found in brain, followed by liver and plasma, whereas
muscle presented the lowest values. Oxazepam was detected in
all exposed ﬁsh except in 3 muscle samples. The tissue-speciﬁc
bioconcentration factors (BCFs) were calculated according to
themeasuredwater concentration and the concentrations in each
tissue, and these are summarized in Table 2. In brain BCFs were
higher when compared to the other tissues, especially at the
lowest exposure concentration, mirroring what has been
observed in previous studies [20,22]. The tissue to plasma
ratios were also calculated and are summarized in Table 2 and
Figure 1A. For all tissues, the ratio between the solid tissue and
plasma concentrations in the lowest concentration, calculated as
the logarithmic concentration (log10), was signiﬁcantly different
from those of the other 2 concentrations. A linear regression of
log-transformed (log10) solid tissue versus plasma concen-
trations was undertaken and is represented in Figure 1B, to
provide an indication of oxazepam organ distribution, as in
Tanoue et al. [23]. Signiﬁcant positive correlations between
plasma and tissue concentrations of oxazepam were found in all
cases (0.47<R2< 0.64, p< 0.05, n¼ 96, Pearson correlation
coefﬁcient). The distribution of oxazepam in ﬁsh supports the
current knowledge of the pharmacokinetic and distribution of
this drug in mammals [24,25].
Benzodiazepines, including oxazepam, are substances able to
cross the blood–brain barrier relatively rapidly [9]. Once in the
brain, these compounds equilibrate with brain tissue and, after
equilibrium is attained, a constant brain to plasma ratio is
maintained so that plasma concentrations are proportionately
related to concentrations in the brain [26]. The present study did
not have multiple time sampling, so it is not possible to ascertain
if that equilibrium was maintained during the exposure period
employed. Nevertheless, the brain to plasma ratio observed in the
present study (2–6:1) is similar to that observed in rats (3–5:1)
[24] and cats (1–3:1) [25], supporting the read-across approach.
Fish plasma concentrations versus HTPC
Measured plasma concentrations were also compared with
the concentrations predicted by the ﬁsh plasma model,
according to the above equations (see Prediction of oxazepam
plasma concentration using the ﬁsh plasmamodel and Figure 2).
The HTPC range used as reference [19] in the present study is
100 ngmL1 to 280 ngmL1. Exposure of ﬁsh to 0.8mg L1
and 4.7mg L1 resulted in plasma concentrations of oxazepam
below the HTPC, whereas exposure to 30.6mg L
1 produced
Table 1. Method validation parameters for the analysis of oxazepam in water and ﬁsh tissues
Precision
(% relative SD)
Recoveries (%)
( relative SD)
Method detection limit
(ngmL1)a
Method quantitation limit
(ng mL1)a Intraday Interday
Matrix effect
(% relative SD)
Water — 0.02 0.06 1.2 2.5 103 (3)
Plasma 78 (13)b 0.04 0.14 7.1 8.7 104 (9)
Brain 106 (14)c 0.54 1.80 0.9 5.3 102 (8)
Liver 102 (11)c 0.12 0.39 0.5 0.3 115 (1)
Muscle 92 (14)c 0.15 0.51 6.1 7.1 99 (3)
aNanograms per gram for tissues.
bPlasma was spiked at 100 ngmL1.
cTissues were spiked at 50 ng g1.
SD¼ standard deviation.
Table 2. Measured concentration of oxazepam in plasma, brain, muscle, and liver at the 3 exposure levelsa
Water Plasma Brain Muscle Liver
Concentration
(mgL1)
Concentration
(ngmL1) BCF
Concentration
(ng g1) BCF
Brain to
plasma ratio
Concentration
(ng g1) BCF
Muscle to
plasma ratio
Concentration
(ng g1) BCF
Liver to
plasma ratio
0.8 9 (3–18) 10.0 40 (17–73) 51 6.6 7 (0–47) 9 1.1 16 (6–50) 20 2.7
4.7 30 (8–80) 6.4 50 (23–91) 10.6 2.1 22 (0–96) 4.8 0.9 39 (10–96) 8.2 1.5
30.6 99 (10–313) 3.3 147 (57–323) 4.8 2.6 82 (7–192) 2.7 1.5 171 (20–439) 5.6 2.5
aConcentration in tissues expressed as mean (minimum–maximum) values.
All values are expressed as average.
DBCF¼ bioconcentration factor.
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plasma concentrations within the HTPC range in several ﬁsh,
particularly in males (9 out of 16 males and 3 out of 16 females).
The ﬁsh plasma model demonstrated a good degree of
accuracy for the prediction of oxazepam uptake in ﬁsh plasma in
general, despite the fact that it does not consider interspecies or
intraspecies variability and that it was developed for very
hydrophobic compounds [27]. However, when male and female
fathead minnows were assessed separately, the model over-
estimated the measured concentrations in female ﬁsh: the
measured concentration was on average 2.7 times lower than the
predicted concentration for females exposed at the highest
concentration. Two hypotheses arise to explain these differ-
ences, although no data are available to test their validity: 1)
gender-speciﬁcmetabolism of oxazepam led to different steady-
state plasma concentrations, and 2) smaller gill surface area per
unit of body weight in females led to lower uptake rates [28].
Previous studies with a different psychoactive drug, ﬂuoxetine,
have demonstrated the occurrence of dose-dependent modula-
tion (e.g., induction, inhibition, saturation) of metabolic
enzymes, which can lead to discrepancies between measured
and modeled concentrations [10]. These dynamics are antici-
pated to occur only at high concentrations and are likely not to
be relevant at environmental concentrations. In the present
study, no metabolites of oxazepam were measured, so the
possibility of this effect occurring in the high concentration
group remains only theoretical.
In humans, sex-speciﬁc differences in pharmacokinetics
have been identiﬁed for many drugs, including benzodiaze-
pines [29]. For instance, a study about the kinetics of oxazepam
in men and women determined that the elimination half-life was
25% longer in females and the clearance of total as well as
unbound oxazepam was signiﬁcantly greater in men than in
women [30]. These differences have been attributed to
variations in size, composition, and hormonal effect, which
Figure 1. (A) Comparative accumulation of oxazepam (log10 tissue/plasma concentration ratio) at the 3 nominal exposure concentrations. (B) Log-linear
correlation between plasma and tissue concentrations of oxazepam in exposed ﬁsh. Pearson correlation coefﬁcients for brain, liver, and muscle were 0.336,
0.5228, and 0.4260, respectively. Boxes represent medians, with 10th and 90th percentiles.
Figure 2. Measured (blue line, mean standard deviation, n¼ 16/treatment) and predicted (red dashed line) plasma concentrations of oxazepam after 28-d
exposure. Gray area indicates the human therapeutic plasma concentration range. HTPC¼ human therapeutic plasma concentration.
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ultimately can affect the drug absorption, distribution, metabo-
lism, and excretion proﬁle, although other studies on
benzodiazepines, including oxazepam, have not found sex
differences in distribution or elimination rates [31,32].
Behavioral effects
Novel tank diving test. In the novel tank diving test,
decreased exploratory activity (p< 0.05) in both the middle and
top areas was observed only for the ﬁsh exposed to 4.7mg L1
(Figure 3 and Table 3). The same group exhibited an increase in
the percentage of time spent in the bottom area. In this group,
plasma concentrations of oxazepam were approximately one-
third of the lowest HTPC value. In contrast, no signiﬁcant effects
were observed in ﬁsh exposed to the lowest concentration
(0.8mg L1) and highest concentration (30.6mg L1). No
indications for signiﬁcant differences between males and
females in behavioral activity were found at any concentration.
Data for individual ﬁsh showed a relatively high interindi-
vidual and intertank variability across treatments, including the
control group (Supplemental Data, Figures S1 and S2). The
latter included ﬁsh with high as well as poor activity, with ﬁsh
from tank 1 demonstrating a higher activity than the other
control ﬁsh. The same control group showed also a behavioral
pattern different from the other controls in the shelter-seeking
test, indicating that such behavior was tank-speciﬁc rather than a
random phenomenon. The consequent increase of variability in
the behavior of the control group inﬂuenced the expected
sensitivity of the 2 behavioral tests used in the present study.
To reinforce the results of the nonparametric statistical
analysis, which compares only the median behavioral outcomes
from the control ﬁsh to the treated ﬁsh, and as a response to the
difﬁcult statistical distribution pattern observed for these
endpoints, a marginal logistic regression analysis on the time
ﬁsh spent on the bottom was conducted (Table 4). The data on
the behavioral endpoints were reduced to dichotomous levels,
selecting either the median response as the criterion for
grouping (balanced approach) or a response considered more
relevant (in the present study: all ﬁsh that spent at least 90.0% of
their time at the bottom). It should be noted that the latter leads
to an unbalanced grouping and therefore reduces the statistical
power to identify possible treatment-related differences in their
group occurrences. The model was set such that it estimates the
probability that a treated ﬁsh is more (or less) likely to occur in
the “upper location” group compared to the controls. Treated
Figure 3. Effect of oxazepam on ﬁsh exploratory behavior quantiﬁed during a novel tank diving test performed after 28 d of exposure. Number of entries into the
top area (A) per treatment (n¼ 32) and (B) in each individual tank (n¼ 8). Time spent in the top area (C) per treatment (n¼ 32) and (D) in each individual tank
(n¼ 8). Males are represented as blue circles and females as pink inverted triangles. Boxes represent medians, with 10th and 90th percentiles.
Table 3. Nonparametric statistical analysis (Kruskal-Wallis tests followed
by Dunn’s post hoc tests)
Oxazepam concentration (mgL1)
Endpoint 0.8 4.7 30.6
Novel tank diving test
% Time spent at the bottom — " —
p¼ 0.38 p< 0.01 p¼ 0.99
% Time spent at the middle — # —
p¼ 0.37 p< 0.01 p¼ 0.98
% Time spent at the top — # —
p¼ 0.12 p< 0.01 p¼ 0.99
Transition to the middle — # —
p¼ 0.17 p< 0.01 p¼ 0.57
Transition to the top — # —
p¼ 0.11 p< 0.01 p¼ 0.99
Distance traveled — # —
p¼ 0.99 p< 0.01 p¼ 0.99
Shelter-seeking test
% Time spent under the shelter — — —
p¼ 0.16 p¼ 0.10 p¼ 0.99
% Time spent outside the shelter — — —
p¼ 0.16 p¼ 0.10 p¼ 0.99
Distance traveled — — —
p¼ 0.10 p¼ 0.11 p¼ 0.99
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ﬁsh were either used as a single group or grouped according to
the tertiles of themeasured drug plasma levels. The probabilities
are expressed as odds ratios: odds ratio¼ 2 means that a treated
ﬁsh has a 2 times higher chance of being in the upper group than
a control ﬁsh, and odds ratio< 1 indicates the opposite behavior,
that the corresponding treatment leads the ﬁsh to staymore at the
bottom.
Among all ﬁsh, thosewith oxazepam plasma levels above the
quantiﬁcation limit were more likely to be at the bottom than
control ﬁsh, especially ﬁsh with low or median plasma levels
(indicated by statistical signiﬁcance). However, the median
behavioral response for the grouping was 99.7%, and
consequently many ﬁsh were allocated to the “upper location.”
A second grouping with ﬁsh having spent at least 90% of their
time at the bottom revealed similar odds ratios below 1 but not
statistically signiﬁcant. The hypothesis is that the observed ﬁsh
behavior in control tank 1 was mainly responsible for these
ﬁndings as data analysis without these data revealed
nonsigniﬁcant odds ratios at approximately 1 (data not shown).
In none of the analyses was any indication for gender
differences found (p values>0.3).Whereas the effects observed
in the 4.7mg L1 group were conﬁrmed by the different
statistical approaches used, additional experiments will be
necessary to clarify the current uncertainty around potential
effects in the 0.8mg L1 exposure group (Table 4). It is also
interesting that on the basis of a previous experiment with
oxazepam, an increase in the exploratory behavior was
expected [8]. However, in the present study a decrease of the
exploratory behavior was observed at 4.7mg L1.
Shelter-seeking test. No signiﬁcant differences in the time
spent under the shelter or the distance traveled in the tank were
observed between the control and treatment groups (see Figure 4
and Table 3; Supplemental Data, Table S4). Male ﬁsh spent on
average 20% more time under the shelter than female ﬁsh,
which agrees with previous studies on fathead minnow
behavior; but these differences were not supported by statistics
(p> 0.3) [33]. Differences were observed between the 4
replicate tanks of the control group. In particular, ﬁsh in tank
1 (control treatment, males) spent more time under the shelter
compared to the ﬁsh in the other tanks (Supplemental Data,
Figure S3).
Logistic regression revealed a positive association between
the time a ﬁsh spent under the shelter and the treatment
(Table 4). Among all ﬁsh, those exposed to oxazepam were
twice as likely to leave the shelter as the control ﬁsh (16.8% of
their time under the shelter), which was used as the criterion for
the balanced grouping. Reﬁning the analysis by using instead
the tertiles of the measured plasma drug levels, only drug
plasma levels above 40.1mg L1 showed a signiﬁcant odds
ratio, with a 3-fold higher chance of a ﬁsh leaving the shelter.
However, when the grouping criterion was changed to “at least
one-third time spent under the shelter,” the outcomes from the
Table 4. Association between oxazepam levels measured in ﬁsh plasma after 28-d exposure and a dichotomized behavior parametera
Bottom reference Upper location
Odds ratio 95% Confidence intervaln % n %
Novel tank diving test (N¼ 112)
Fish spent at least 99.7% of their time at the bottom (balanced approach)
Control 7 25.9 20 74.1 1.00 —
0–13.3 12 42.9 16 57.1 0.45* 0.21–0.99
13.3–40.1 22 75.9 7 24.1 0.11* 0.03–0.36
>40.1 15 53.6 13 46.4 0.31 0.09–1.04
Fish spent at least 95.0% of their time at the bottom
Control 16 59.3 11 40.7 1.00 —
0–13.3 22 78.6 6 21.4 0.38 0.09–1.60
13.3–40.1 25 86.2 4 13.8 0.24 0.04–1.39
>40.1 21 75.0 7 25.0 0.49 0.09–2.62
Fish spent at least 90.0% of their time at the bottom
Control 20 74.1 7 25.9 1.00 —
0–13.3 25 89.3 3 10.7 0.39 0.12–1.29
13.3–40.1 26 89.7 4 10.3 0.31 0.04–2.29
>40.1 24 85.7 4 14.3 0.44 0.07–2.65
Shelter-Seeking test (N¼112)
Fish spent at least 16.8% of their time at the bottom (balanced approach)
Control 18 66.7 9 33.3 1.00 —
0-13.3 11 40.7 16 59.3 3.86 0.91–16.30
13.3-40.1 16 55.2 13 44.8 1.89 0.80–4.46
>40.1 11 37.9 18 62.1 2.96* 1.12–7.79
Fish spent at least 1/3rd of their time at the bottom
Control 12 44.4 15 55.6 1.00 —
0–13.3 9 33.3 18 66.6 1.74 0.33–9.19
13.3–40.1 11 37.9 18 62.1 1.37 0.50–3.77
>40.1 9 31.0 20 69.0 1.70 051–5.65
Fish spent at least half of their time at the bottom
Control 3 11.1 24 88.9 1.00 —
0–13.3 3 11.1 24 88.9 0.83 0.07–10.13
13.3–40.1 3 10.3 26 89.7 0.97 0.09–10.89
>40.1 5 17.2 24 82.8 0.63 0.06–7.11
aOdds ratios were estimated by marginal logistic regression, controlled by tank effect, adjusted for gender, and corrected by multiple comparisons (Dunnett).
Plasma levels were grouped into 3 even classes according to their tertiles; behavior parameter was dichotomized by its median into 2 even groups (balanced
approach) or uneven groups (unbalanced approach).
* Indicates statistical signiﬁcance (p< 0.05).
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previous analysis were not conﬁrmed, with odds ratios being
always lower and nonsigniﬁcant. In none of the analyses did we
observe signiﬁcant gender-related differences (p> 0.2).
Ecological relevance of the observed behavioral effects
Despite the potential ecological consequences of behavioral
alteration, the main challenges are 1) to be conﬁdent of the
reproducibility of the results, and 2) to know how to translate
any subtle effects observed in laboratory studies to the ﬁeld.
Previous studies have shown that fathead minnows exposed to
environmentally relevant mixtures of 4 different psychiatric
drugs impacted predator-avoidance behavior (an endpoint of
high ecological relevance) [34]. However, results from other
studies have been contradictory: while exposure to sertraline
induced fathead minnowmales to spend less time sheltering as a
result of altered nest guarding behavior [17], exposure to
ﬂuoxetine, a drug with the same mode of action, resulted in an
increase in the same endpoint [34]. Remarkably, fathead
minnows have been shown to react in different ways when
exposed to stress: sometimes they become motionless (“freez-
ing”), for periods ranging from approximately 0.5min to greater
than 8min; in other cases, they swim more slowly or they spend
less time outside the shelter or the opposite: sudden unpredict-
able dashing may happen as an initial response to danger. In
other cases, there is no apparent response [35]. This serves to
highlight the inherent variability of behavioral data measured in
fathead minnow as a model species.
The way to translate this contrasting information into
ecological predictions is currently uncertain; however, steps
forward have been achieved by Hellström et al. [36], who
successfully applied Global Positioning System technology to
track the exploratory behavior of individual ﬁsh in a Swedish
artiﬁcial lake. In the future these technologies may promote an
understanding of the ecological relevance of chemical-induced
behavioral effects by monitoring such effects with the animals
in their natural environment rather than one in which normal
behavior is likely to be altered prior even to the introduction to
test substances of interest.
CONCLUSIONS
In the present study, we successfully characterized the
uptake and distribution of oxazepam in several tissues of
fathead minnow, following 28-d exposure. Drug-related
behavioral effects in exploratory behavior were observed in
ﬁsh exposed at the medium concentration (4.7mg L1) for the
novel tank diving test and at the highest concentration in the
shelter-seeking test. Although the highest exposure concen-
tration produced plasma concentrations of the drug that were
close to, or within, the human therapeutic range, statistically
signiﬁcant effects on the exploratory behavior of the fathead
minnow were only detected with very robust statistical
analysis and only under certain conditions. According to the
read-across approach [5,16], the closer the drug concentration
in ﬁsh plasma is to the HTPC, the higher is the probability of
observing the effect (i.e., behavioral alterations) [16]. The
present results provide no clear indications for a dose
response–related trend and, therefore, leave a signiﬁcant
degree of uncertainty around the internal concentrations of
oxazepam that do or do not cause behavioral effects in fathead
minnow and what aspects of behavior are changed. Future
behavioral studies involving fathead minnow should therefore
be designed to have higher statistical power than that of the
present study to minimize the risk of data misinterpretation.
Moreover, previous studies with other ﬁsh species (Perca
ﬂuvialis) [8] observed increased activity and boldness after
treatment with oxazepam. These apparent interspecies differ-
ences, together with the uncertainties in regard to the observed
dose-response data in the present study and the difﬁculties
developing an optimal experimental design, highlight the
challenge to generate predictions on potential behavioral
changes induced by psychoactive drugs in adult ﬁsh that can
be systematically extrapolated to all species.
Supplemental Data—The Supplemental Data are available on the Wiley
Online Library at DOI: 10.1002/etc.3448.
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